🎉Congratulations to our co-founder @anantm, 𝟮𝟬𝟮𝟱 𝗔𝗔𝗔𝗦 𝗙𝗲𝗹𝗹𝗼𝘄. Dr. Madabhushi’s dedication to 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗮𝗻𝗱 𝗽𝗿𝗼𝗺𝗼𝘁𝗲 𝗵𝗲𝗮𝗹𝘁𝗵 𝗲𝗾𝘂𝗶𝘁𝘆 is at the heart of what we do. #AAASFellow #AIinHealthcare #PrecisionMedicine

Diving deep into AI imaging biomarkers for immunotherapy at #IO360Summit! Our team is on-site having great conversations about accelerating oncology clinical trials. #IO360 #ImmunoOncology #ClinicalTrials #Oncology #AI #PrecisionMedicine

Exciting News! 🚀 Introducing QVT phenotypes—AI imaging biomarkers quantifying tumor vascular properties non-invasively. Join us at ESMO IO 2024 for our mini oral presentation on NSCLC ICI prediction results. #PrecisionOncology #ESMOImmuno24 #Cancer #AIinHealthcare

Today only! Experience our AI-based therapy response prediction (for research use only) live on the #RSNA24 floor. We will be demoing CheckpointPx* ICI treatment response prediction for NSCLC at #RSNA24 at the North Hall Level 3- Booth 101.

Showing our advanced #radiomics that quantify biological properties of tumors, draw new insights on therapy response and build interpretable AI biomarkers at #RSNA24 on Monday @ Booth 101. Want to test this technology works on your data? Contact us and we’ll make it happen!

Overwhelmed by the interest in our interpretable response prediction biomarkers at #SITC2024! Thanks to all who shared images to see it in action. Missed us at SITC? Email us at [email protected] to see what the buzz was about. #Immunotherapy #SITC24 #PrecisionOncology

Showing live demos at #SITC, booth 1223- of advanced #radiomics and explainable #AI biomarkers that quantify biological properties. Also our poster session, abstract 112 (hubs.li/Q02XdYwQ0) will show how #radiomics and #mulitmodal AI improve response prediction in LuAd.

See how our interpretable, predictive AI (RUO) works with your data at #SITC24. Send us a Lung CT image (hubs.li/Q02W9yph0) and visit us at booth 1223 during SITC to see the results! Also visit poster 112 showing #multimodal #AI improving response prediction in LuAD

Today’s IO biomarkers are not working. See how radiomics and multimodal AI can add missing information to current, incomplete biomarkers at #SITC22 Also visit abstract 112 (hubs.li/Q02VfC760) showing how #radiomics and #multimodal #AI improve response prediction.

#Cancer is #multimodal and so are we! We'll be presenting our poster in advancing #immunotherapy response prediction for cancer patients via digital pathology at #ESMO24 on Sunday, September 15 in Hall 6: tinyurl.com/esmo24PH Book a time with us: hubs.li/Q02PBhjj0

Exciting news! We'll be presenting a poster presentation at ESMO. Thrilled to showcase our first pathology paper, on our journey to build multimodal AI biomarkers. Attending? Let's connect and discuss potential collaborations. #ESMO2024 #AI #Biomarkers

It was a pleasure to be in the 6th @pharmstars spring cohort - we connected with excellent colleagues, benefited enormously from our mentors, and graduate with clear focus on the value of interpretable, multimodal biomarkers for the future of cancer care. bit.ly/3zsOd7V

Excited to share these three posters tomorrow at #ASCO24 . Visit us to learn more about our explainable AI signatures and how we can build custom systems predictive of response to therapy and adverse events #AI #Radiology #Biomarker #explainableai #airadiology

We'll exhibit three posters at ASCO (picturehealth.com/asco) showing how our AI biomarkers can better predict response to therapy, and identify patients at risk of progression and adverse events. Meet with us: calendar.app.google/4mDVpuN7… #ASCO2024 #AIinHealthcare #CancerResearch

Thank you @ClevelandClinic for selecting Picture health as a winner to the Quantum Innovation Catalyzer Program- delighted to work with the Cleveland Clinic and @IBM to further Precision Oncology loom.ly/CLwhb9o

Congratulations to our Founder, @anantm for a compelling #AACR plenary presentation: Integrating AI, Radiology and Pathology for Affordable and Equitable Precision Medicine

Presenting 2 external validations with our partners at @NUFeinbergMed 9:00A-12:30P. Automated segmentation (2595/22) and pneumonitis risk prediction models (2594/21) #AACR #AACR2024 #Immunotherapy #AI #ClinicalTrials #Biomarkers loom.ly/pFA4tEg loom.ly/sVFdA1M

Presenting 2 external validations with our partners at @NUFeinbergMed 9:00A-12:30P. Automated segmentation (2595/22) and pneumonitis risk prediction models (2594/21) #AACR #AACR2024 #Immunotherapy #AI #ClinicalTrials #Biomarkers loom.ly/pFA4tEg loom.ly/sVFdA1M

We're #AACR-bound - come to our poster sessions or schedule some time with us to learn more about our explainable AI biomarkers. Also, don't mis our founder, @anantm at the plenary session on Wednesday morning: loom.ly/Ojf9On8